31-45 of 981
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart MattersSubcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Heart MattersReducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Stephanie Dixon, MD, MPH
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Heart MattersAdapting CV Risk Reduction Strategies for Cancer Survivorship
Stephanie Dixon, MD, MPH
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Heart MattersA Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
CardiologyAPOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
Bruno Batinica, MD
- advertisement
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights
Heart MattersAnticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights
Charles Turck, PharmD, BCPS, BCCCP
Akshay Kumar, MD
Plozasiran for Severe Hypertriglyceridemia: 12-Month Results From the SHASTA-3 and SHASTA-4 Trials at ESC
CardiologyPlozasiran for Severe Hypertriglyceridemia: 12-Month Results From the SHASTA-3 and SHASTA-4 Trials at ESC
Prof. dr. Gerald Watts
New Universal Definition Reframes Heart Failure Beyond Ejection Fraction
AudioAbstractsNew Universal Definition Reframes Heart Failure Beyond Ejection Fraction
Ryan Quigley
A Systematic Framework for Pediatric Acute Decompensated Heart Failure
Heart MattersA Systematic Framework for Pediatric Acute Decompensated Heart Failure
A More Complete View of Cardiovascular Risk in Women
Heart MattersA More Complete View of Cardiovascular Risk in Women
Noel Bairey Merz, MD
- advertisement
Updated AACE Guidance on Managing Dyslipidemia in T2D
Heart MattersUpdated AACE Guidance on Managing Dyslipidemia in T2D
Scott D. Isaacs, MD FACP, FACE
Complication-Centric Diabetes Care: Addressing Obesity and Cardiometabolic Risk
Heart MattersComplication-Centric Diabetes Care: Addressing Obesity and Cardiometabolic Risk
Scott D. Isaacs, MD FACP, FACE
The Role of TTR Stabilization in ATTR-CM Treatment
On the Frontlines of ATTR-CMThe Role of TTR Stabilization in ATTR-CM Treatment
Steve Jackson, PharmD
Sumeet Mitter MD, MSc, FACC